understanding glp 1 Drugs: What They Are and Why People Take Them GLP-1 Therapy Part 1: Setting
Description
This connection between the gut & pancreatic islets may be responsible for ~50% of postprandial insulin release (Perley & Kipnis, J Clin Invest 46:1954-1962
BMJ, 335(7631), 1194-1199
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis
Avoid long gaps
two minutes), meaning it gets degraded quickly by digestive enzymes
The pathophysiology involves mechanical insufficiency of the lymphatic system, leading to fluid stasis, chronic inflammation, adipose tissue deposition, and progressive fibrosis
